❌

Normal view

Received — 9 October 2025 ⏭ Epigenetics

Most Recent Articles: Clinical Epigenetics
The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells Anjali Singh · Abhiram Natu · Flevia Anthony · Hemalatha Muthu · Bharat Khade · Duane T. Smoot · Hassan Ashktorab and Sanjay Gupta
Acquired therapy resistance is a dynamic process associated with early epigenetic modifications reshaping gene transcription across multiple cellular pathways, ultimately giving rise to drug-tolerant persister...
8 October 2025 at 08:00

The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells

Most Recent Articles: Clinical Epigenetics

By: Anjali Singh · Abhiram Natu · Flevia Anthony · Hemalatha Muthu · Bharat Khade · Duane T. Smoot · Hassan Ashktorab and Sanjay Gupta

8 October 2025 at 08:00

Acquired therapy resistance is a dynamic process associated with early epigenetic modifications reshaping gene transcription across multiple cellular pathways, ultimately giving rise to drug-tolerant persister...